Breakthrough in Mesothelioma Treatment: Cellectis’ Promising CAR-T Therapy
Mesothelioma is a challenging cancer with limited treatment options. Yet, recent advancements in CAR-T therapy are bringing new hope to the table. There is a breakthrough that holds the potential for improving mesothelioma treatment outcomes. Data comes from Journal for ImmunoTherapy of Cancer. CAR-T Therapy: A New Frontier for Mesothelioma CART T-cell therapy for mesothelioma is a type of immunotherapy. It starts with T-cells from the patient’s blood. Scientists alter the cells to recognize certain antigens on the surface of cancer cells. Then they give them back to the patient. In the case of mesothelioma, the main targeted antigen is mesothelin. Mesothelioma patients tend to produce extra mesothelin. This protein helps drive the growth and spread of their cancer. People with high levels…